We’re excited to announce that we have submitted a 510(k) application to the U.S. FDA for our NiCO™, Noninvasive CO-Oximeter device. This cutting-edge device uses precise laser technology to directly measure blood oxygen levels, offering a significant advancement over traditional LED-based oximeters. The FDA submission marks a historic milestone in the evolution of pulse oximetry and a significant breakthrough for the company. To read the full press release: https://lnkd.in/gz8dqTrh #Zynex #ZynexMedical #ZynexMonitoring #ZMS #InnovationInHealthcare #PulseOximeter #MedicalTechnology #FDASubmission #HealthEquity #NiCO #LaserTechnology
Congratulations on this huge step. Zynex Medical your commitments and continued innovation in this space is incredible.
Media Consultant | B2B Healthcare Publications | Lead Gen | Branding | Thought Leadership | Supporting MedTech & Healthcare Marketers
2moCongratulations on this important milestone! At B2B Hospital & Healthcare Management, we’re always keen to spotlight groundbreaking advancements like NiCO™ that are shaping the future of patient care. With our upcoming magazine issue and digital promotional platforms, we’d be glad to explore opportunities to feature this innovation and support broader visibility across the global healthcare community. Let’s connect!